We Develop Proprietary Peptide Drugs for Outpatient Therapy


Our programs include: 

  • Refractory Ascites 
  • Lung Diseases:
    – Acute Respiratory Distress Syndrome (ARDS)
    – Pulmonary Fibrosis (PF)
    – Pulmonary Hypertension (PH)
  • Cancer Immunotherapy 
  • Refractory Hypertension 

AsahiKasei, PeptiDream, and Shionogi are our partners/investors.


We welcome additional partners for in-/out-licensing/co-development and go-to-market.

Please contact us:

PharmaIN Corporation
11812 N Creek Parkway N, Ste. 101
Bothell, WA 98011 USA